Temozolomide (Temodar®) and capecitabine (Xeloda®) treatment of an aggressive corticotroph pituitary tumor

Author: Thearle Marie  

Publisher: Springer Publishing Company

ISSN: 1386-341X

Source: Pituitary, Vol.14, Iss.4, 2011-12, pp. : 418-424

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract